Huanwen Wu

ORCID: 0000-0002-3996-3176 · 4 papers in corpus
other 2024
Clinical and translational medicine ·doi:10.1002/ctm2.1809
2021
Frontiers in oncology ·doi:10.3389/fonc.2021.798173

Ovarian clear cell carcinoma (OCCC) is aggressive and drug-resistant. The prevalence of homologous recombination repair (HRR) gene mutations and homologous recombination deficiency (HRD) remains largely unknown. It is also not clear whether…

article 2020
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.13573

OBJECTIVE: To investigate the significance of perioperative levonorgestrel-releasing intrauterine system (LNG-IUS) and/or gonadotropin-releasing hormone agonists (GnRHa) as adjuvant therapy in preventing recurrences or progression of diseas…

article 2020
Scientific reports ·doi:10.1038/s41598-020-63065-w

Little is known about the epidemiological and clinicopathological characteristics of endometrial endometrioid carcinoma (EEC) coexisting with or arising in adenomyosis (EEC-A or EEC-AIA) due to their rarity. This study compared EEC-A and EE…